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ABSTRACT 
Background: Renal diseases information is population-based and has great geographic variability. Due to the lack of 
national renal data registry system, there is no information on the prevalence rate, and clinical and laboratory features of 
various glomerulonephritidies (GNs) in Iran. 
 
Methods: In a retrospective cross sectional study, we analyzed 462 adult renal biopsies in Hashemi Nejad hospital, 
Tehran, Iran. We determined the prevalence rate and the frequency of different clinical and laboratory findings in 
patients with different GNs. We also compared our results with the reports from other countries. 
 
Results: There were 267(57.8%) males and 195(42.2%) females. The mean age (± SD) was 33.6 ± 15.7 (range, 13-75) 
years old. After exclusion of 55 biopsies with pathologies other than GNs and in the remaining 407 biopsies, 
membranous glomerulopathy (MGN) was the most common GN (23.6%), followed by IgAN (13.5%), 
membranoproliferative GN (11.5%), systemic lupus nephritis (10.6%), focal segmental glomerulosclerosis (10.3%), and 
minimal change disease (9.8%). These 6 GNs comprised the majority (79.4%) of all GNs. 
 
Conclusion: MGN is the most common form of GN, followed by IgAN, MPGN, SLE-GN, FSGS and MCD in adult 
patients in our study. The multi-center studies with a larger sample size are needed for more comprehensive data in 
Iranian population. 
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lomerulonephritidies (GNs) remain the  
third most  common cause of end stage 
renal failure 1. Epidemiological data of 
renal diseases is population-based and has 
great variability according to the geographic 
area, socioeconomic condition, race, biopsy 
indication, and differences in genetic 
susceptibility and environmental exposure 2-5.  
    Due to the lack of a nationwide renal data 
registry system, there is no information on the 
frequency of different GNs in Iran. 
Furthermore, the great variability of clinical 
manifestations confounds the determination of 
a definitive diagnosis based on the clinical 
features alone 6, and therefore, kidney biopsy  
remains the gold standard test for the 
diagnosis of GNs. However, it is invasive, has 
some associated morbidity, and in some 
circumstances may be contraindicated. Due to 
the great variety of glomerular diseases, 
approach to the patients heavily relies on the 
clinical, laboratory and pathologic findings 6. 
More analysis of clinical and laboratory 
findings in these patients could be helpful in 
developing more definitive criteria for 
diagnosis, identifying risk factors, prognosis, 
and predicting the outcome. In this study, we 
analyzed the clinical and laboratory findings of 
kidney biopsies from different forms of GNs, 
and compared our results with the reports 
from other countries. 
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Materials and Methods 
In a retrospective cross sectional study, we 
analyzed renal biopsies performed from 1998 
to 2001 in HashemiNejad hospital as an adult 
referral university medical center in Tehran, 
Iran. 
    Indications for renal biopsy were:   
idiopathic nephrotic syndrome in adult before 
empiric therapy, rapidly progressive renal 
failure caused by GNs, evaluation and follow 
up for collagen diseases, predominantly SLE 
with proteinuria, abnormal urine 
sedimentation or reduced renal function, 
glomerular proteinuria with unknown cause 
accompanied by abnormal urine sedimentation 
or quantitive persistent proteinuria of urine 
more than 1gr/d, persistent or recurrent 
glomerular hematuria with proteinuria more 
than 500 mg/dl and acute renal failure(ARF) 
with unknown cause in normal kidney size 
without obstruction 7.  
    Renal biopsies were processed for light and 
immunofluorescence microscopy in all 
specimens. In all cases, sections were stained 
for Hematoxylin and Eosin (H&E), Masson's 
trichrome, periodic acid-Schiff (PAS), and 
Silver Jone's stain. 
    Clinical information was obtained from the 
biopsy requisition forms, and by reviewing the 
patients' medical records. All data related to 
the final diagnosis, age, sex, clinical 
presentation, serum levels of cholesterol, 
triglyceride, creatinine, complements (C3, C4 
and CH50), microscopic hematuria, 
hypertension (systemic BP>140/90 mmHg), 
and proteinuria were recorded. Based on 
diagnostic criteria, clinical presentations were 
classified as;  
a) nephrotic syndromes: proteinuria more than 
3.5 gr/1.73m2 /24h;  
b) nephritic syndromes: syndrome with 
hematuria, RBC cast, azotemia, oliguria, edema 
and HTN; 
 c) ARF: rapid decline in glomerular filtration 
rate (GFR) during few days to few weeks;  
d) CRF: azotemia for more than 3 months;  
e) AUA: syndrome with hematuria, 
proteinuria less than nephrotic syndrome, 
sterile pyuria and casts without any symptoms;  
f) RPGN: documented recent decline in GFR 8. 
    The data were analyzed by SPSS, using 
ANOVA between different clinical or 
pathological diagnoses, and mean ± SD values 




We reviewed 462 adult renal biopsies, 407 
(88%) of which had shown some form of GNs. 
There were 267 (57.8%) males and 195 (42.2%) 
females; the mean age was 33.6 ± 15.7 years 
(ranged from13 to75). 
    Membranous glomerulopathy (MGN) was 
the most common GN (23.6%), followed by 
IgAN (13.5%), membranoproliferative GN 
(MPGN) (11.5%), systemic lupus nephritis 
(SLE-GN) (10.6%), focal segmental 
glomerulosclerosis (FSGS) (10.3%), and 
minimal change disease (MCD) (9.8%).  These 
6 GNs comprised the majority (79.4%) of all 
GNs. More details are shown in Table 1.  
    The frequency of presenting syndromes in 6 
common GNs is presented in Table 2. 
Proteinuria was present in almost all patients 
in 6 common GNs. The frequency of 
hypertension, microscopic hematuria, 
hypertriglyceridemia, hypercholesterolemia, 
and serum creatinine > 1.4 mg/dl, at the time 
of presentation are shown in Table 3. 
    After using ANOVA test among 6 most 
common GNs, there was no significant 
difference in triglyceride concentrations 
(p=0.27) but, the difference was significant in 
regard to serum cholesterol or creatinine 
concentration and proteinuria (p<0.005). 
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Table1. Age, male to female ratio and laboratory findings at the time of presentation  

















MGN 1.5:1 43.1±14.8 7268 ± 4003 
(1200-25500) 
363 ± 110 
(130-674) 
290 ± 154 
(75-842) 
1.3 ± 1.8 
(0.5-15.0) 
IgAN 3.2:1 32.8±12.3 3924 ± 3089 
(600-15000) 
251 ± 79 
(147-484) 
242 ± 150 
(87-957) 
2.2 ± 2.5 
(0.6-14.8) 
MPGN 1.2:1 28.6±15.9 5470 ± 3455 
(86-14300) 
278 ± 79 
(145-434) 
266 ± 231 
(69-1550) 
1.9 ± 1.4 
(0.5-7.9) 
SLE-GN 0.1:1 24.4±8.0 5154 ± 3472 
(390-12500) 
286 ± 109 
(123-530) 
299 ± 171 
(83-864) 
2.3 ± 2.2 
(0.5-11.3) 
FSGS 1.9:1 30.4±13.4 5762 ± 4834 
(750-20600) 
312 ± 112 
(147-646) 
304 ± 17 
(129-890) 
2.8 ± 3.3 
(0.5-16.1) 
MCD 1.3:1 34.9±15.2 7823 ± 3887 
(2200-21000) 
398 ± 119 
(164-672) 
333 ± 175 
(91-755) 
1.2 ± 1.0 
(0.5-6.2) 





Table 2. The frequency of presenting syndromes in different GNs 
Diagnosis Presenting 




MPGN SLE-GN FSGS MCD Total 
Nephrotic 81(84.5) 25(45.5%) 31(66%) 28(65%) 24(57%) 38(95%) 226(70%) 
Nephritic 10(10.5%) 18(33%) 6(13%) 9(21%) 8(19%) - 51(16%) 
ARF - 1(2%) 4(8.5%) 3(7%) 4(9.5%) 1(2.5%) 13(4%) 
CRF 2(2%) 5(9%) 3(6.5%) 1(2%) 2(5%) - 13(4%) 
AUA 3(3%) 6(11%) - 2(5%) 3(7%) 1(2.5%) 15(5%) 
RPGN - - 1(2%) - 1(2.5%) - 2(0.5%) 
Unknown - - 2(4%) - - - 2(0.5%) 
Total 96 55 47 43 42 40 322 





Table 3. The frequency of hypertension, hematuria, serum creatinine, and hyperlipidemia 
in different GNs 









MGN 37(38.5%) 13(13.5%) 62(64.6%) 85(88.5%) 15(15.6%) 
IgAN 27(49%) 22(40%) 23(42%) 30(54.5%) 19(34.5%) 
MPGN 28(60%) 16(34%) 25(53%) 34(72.5%) 27(57.5%) 
SLE-GN 23(53.5%) 15(35%) 25(58%) 29(67.5%) 22(51%) 
FSGS 25(59.5%) 8(19%) 23(55%) 29(69%) 23(55%) 
MCD 10(25%) 5(12.5%) 27(67.5%) 35(87.5%) 7(17.5%) 
Total 150 79 185 242 113 
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In our series, MGN was the most common 
form of GN (23.6%), followed by IgAN, MPGN, 
SLE-GN, FSGS and MCD. They comprised 
79.4% of our total native kidney biopsies. 
    MGN is the most common cause (25%) of 
idiopathic nephrotic syndrome in adults, 
world wide 1,6, with male to female ratio as 2:1, 
peak incidence in 4th and 5th decades of life and 
significant geographic variation in its clinical 
manifestations. Patients from Australia and 
Japan have a lower frequency of nephrotic 
syndrome, as compared to patients from 
Europe or North America6. We found a high 
incidence of nephrotic syndrome (84.5%) at the 
time of presentation (mean protein excretion 
rate, 7.3 grams/24 hours), that may be due to 
severity of disease in patients at the time of ad- 
mission to our hospital as a referral center for 
renal disease in Tehran, Iran. 
    IgAN is now regarded as the most common 
form of GN in the world 6, 10, 11. Its prevalence 
rate varies in different geographic regions 8; 
most prevalent in Asia (30-40%), also quite 
prevalent in Europe (20%), but less common in 
North America (10%) 10, 11. Its incidence varies 
from 2 per 10,000 populations in France and 
Germany to 2.0%-4.8% of population in 
Singapore 6, 11, and its male to female ratio is 
2:1 6.  In our series, low IgAN prevalence may 
be related to our late stage criteria for renal 
biopsy such as excluding the patients with 
isolated hematuria and proteinuria <1gr/dl. 
we haven’t screening plan for early stage of 
disease for example in school age children, and 
we only evaluate patients with proteinuria 
more than 500 mg/dl or raising in serum 
creatinine level whereas isolated hematuria 
contains many new IgAN cases that may be 
missed.  
 Country [references] Year Number MGN IgAN MPGN SLE-GN FSGS MCD 
89-94 186 10.8% 10.8% 7.5% 8.6% 32.3% 1.1% 1 Saudi Arabia [17,18] 
89-97 166 9.0% 18.9%. 4.5% - 17.1% 9.9% 
2 United Arab 
Emirates [4] 78-96 490 20.1% 6.3% - - 18.3% 18.3% 
3 United States [19] 1996 340 33.0% 7.0% 6.0% - 34% 16.0% 
4 Italy [20] 1996 1926 20.0% 26.0% 7.3% - 7.8% 5.9% 
5 Japan [20] 1999 1850 10.6% 26.8% 7.1% - - 15.7% 
6 China [20] 79-00 10002 10.5% 39.5% 40.4%  5.2% 1.2% 
7 Denmark [21] 85-97 2380 11.5% - 5.1% - 13.6% 17.5% 
8 Korea [3] 73-95 3616 11.8% 22.1% 5.9% 6.4% 4.6% 26.6% 
9 Australia [5] 95-97 1147 10.6% 34.1% 2.2% 13.9% 16.9% 4.4% 
10 Malaysia [22] 94-00 407 4.4% 9.8% - 31.0% 4.9% 28.5% 
11 Lima/Peru [23] 85-95 1263 - 0.9% 14.8% 30.2% 13.9% - 
12 Macedonia [24] 75-01 1304 13.5% 11.8% 8.4% - 9.9% 7.2% 
13 Kuwait [25] 95-01 584 5% 7.9% - - 18.0% 13.0% 
14 Hong Kong [26] 93-97 1629 8.3% 23.9% - 20.5% 4.7% 8.8% 
70-99 4400 13.4% - 48.9% - 7.8% 5.6% 15 Moscow [27,28] 
78-83 1031 7.5% - - - 14% 11.7% 
16 Zaire [29] 86-89 92 10% - 8% - 41% 14% 
79-99 943 14.8% 11.5% 11.5% - 29.5% - 17 Brazil [30,31] 
90-93 206 20.4% 10.2% 14.1% - 43.2% 5.3% 
18 France [32] 76-90 942 17.7% 33.4% 6.6% - 10.6% - 
19 Iran [33] 81-94 713 15.7% 1.2% 14.8% 12.6% 6.7% 11.3% 
20 Iran [present study] 98-01 407 23.6 13.5 11.5 10.6 10.3 9.8 
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    FSGS comprises 2-41% of primary GNs in 
the world 2. In the past 20 years, prevalence 
rate of primary FSGS has risen from < 10% to 
25% of adult primary GNs 6. FSGS comprises 6-
15% of GNs in Europe and 2-11% of GNs in 
Asia 2. FSGS is slightly more common in males 
(M:F ratio, 1.4 : 1). In Cattran report, half of 
adult patients had nephrotic syndrome at 
presentation 1. In our series, mean protein 
excretion rate was 5.8 gram/24 hours, and 57% 
of FSGS patients presented with nephrotic 
syndrome. 
    MCD is responsible for 10-15% of primary 
nephrotic syndromes in adults 6. It has a 
variable geographic distribution, being more 
common in Asia than North America or 
Europe 12, and is equally distributed between 
two sexes 6.  
    Recent studies have focused on the 
significance of epidemiologic and clinical 
features of SLE-GN, and report a female to 
male ratio of 8-13:1 13.  In our series, SLE-GN 
accounted for 10.6% of all GNs; the patients 
were the youngest (average age, 24.4 years) 
among all GNs, 10 times more females than 
males, 65% with nephrotic syndrome, and only 
21% with a nephritic picture.  
    MPGN accounts for a wide range (2% to 49%; 
average, 12.5%) of GNs worldwide; 50% with 
nephrotic syndrome, and 30% with mild and 
asymptomatic proteinuria 6. In our series, 
MPGN accounted for 11.5% of all GNs, with 
average age of 28.6 years. There were slightly 
more males (M: F ratio 1.2:1), and almost all 
patients presented with proteinuria (average of 
5.5 gr/day).  In Iran, hepatitis B prevalence is 
reported low (1.07%) and high (8.96%) in 
different provinces 14, 15, and a ten-time higher 
incidence of hepatitis C was noted in Iranian 
MPGN patients in comparison with normal 
population 16. In our study, we haven’t any 
available information on the hepatitis B or C 
status of the MGN or MPGN patients and 
consequently related result could be influenced by 
this fact. 
   The frequency of different GNs in other 
geographic regions of the world is presented in 
Table 4. Unfortunately, many reports lack detailed 
information about clinical and laboratory indices. 
MGN, which is the most common GN in our 
series, has also been reported as the most common 
GN in United Arab Emirates, and Macedonia, and 
among the top in USA. 
    Recent data points to the genetic and biologic, 
as well as, socioeconomic factors that may be 
contributing to these findings 34.  The contribution 
of clinical epidemiology to evidence-based 
nephrology is not limited to randomized 
controlled trials 35.  Epidemiological studies on the 
prevalence rate, and clinical and laboratory 
findings can lead to a higher index of suspicion to 
a particular diagnosis that may lead to a 
therapeutic intervention at a more timely fashion. 
Whether racial and socioeconomic data should be 
used in treating individual patients, and how, 
remains controversial. Moreover, like other fields 
in medical research, epidemiology has some 
methodological limitations that must be taken into 
account 35. 
    Our study has several shortcomings. We did 
not elaborate on the remaining variants of GNs, 
sub-types of MPGN (I or II), or associated 
conditions such as malignancy or drug 
consumption. Further studies with larger sample 
size and survival analysis of patients are needed 
for better understanding of the epidemiologic 
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